Failure of magnesium in treatment of Irukandji syndrome [6]

Anaesthesia and Intensive Care

Volumn 33, Issue 4, 2005, Pages 541-542

  Little, M ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; GLYCERYL TRINITRATE; INOTROPIC AGENT; MAGNESIUM; OPIATE; VENOM;

ADULT; CASE REPORT; DISEASE SEVERITY; ENVENOMATION; HUMAN; HYPOTENSION; INTENSIVE CARE UNIT; INTUBATION; IRUKANDJI SYNDROME; JELLYFISH; LETTER; LUNG EDEMA; MALE; PATIENT CONTROLLED ANALGESIA; TREATMENT FAILURE;

ADULT; ANALGESICS; ANALGESICS, OPIOID; BITES AND STINGS; BRONCHODILATOR AGENTS; CNIDARIAN VENOMS; EPINEPHRINE; HUMANS; HYPERTENSION; HYPOTENSION; INTUBATION, INTRATRACHEAL; MAGNESIUM SULFATE; MALE; NITROGLYCERIN; PAIN; PULMONARY EDEMA; SWEATING; SYNDROME; TACHYCARDIA; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 23644436875     PISSN: 0310057X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Corkeron M, Pereira P, Makrocanis C. Early experience with magnesium administration in Irukandji syndrome. Anaesth Intensive Care 2004; 32:666-669.
2. Bailey PM, Little M, Jelinek GA et al. Jellyfish envenoming syndromes: unknown toxic mechanisms and unproven therapies. Med J Aust 2003; 178:34-37.
3. Ramasamy S, Isbister GK, Seymour JE et al. The in vivo cardiovascular effects of the Irukandji jellyfish (Carukia barnesi) nematocyst venom and tentacle extract in rats. Toxicol Lett 2005; 155:135-141.
4. +, haemolysis and Artemia sp lethality. Toxicon 2005; 45:233-242.